Pharmacokinetics of high dosage of linezolid in two morbidly obese patients.
暂无分享,去创建一个
V. Ranieri | V. Fanelli | F. D. De Rosa | G. di Perri | A. D’Avolio | R. Urbino | S. Corcione | L. Baietto | N. Pagani
[1] Kimberly B. Lee,et al. Subtherapeutic Linezolid Concentrations in a Patient with Morbid Obesity and Methicillin-Resistant Staphylococcus aureus Pneumonia: Case Report and Review of the Literature , 2013, The Annals of pharmacotherapy.
[2] D. Nicolau,et al. Pharmacokinetics of Intravenous Linezolid in Moderately to Morbidly Obese Adults , 2012, Antimicrobial Agents and Chemotherapy.
[3] K. Thursky,et al. Dosing of antibiotics in obesity , 2012, Current opinion in infectious diseases.
[4] E. Yukawa,et al. Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient , 2012, Scandinavian journal of infectious diseases.
[5] A. Canut,et al. Pharmacokinetic–pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries , 2012, European Journal of Clinical Microbiology & Infectious Diseases.
[6] J. Xing,et al. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients. , 2011, International journal of antimicrobial agents.
[7] P. Viale,et al. Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis , 2010, Antimicrobial Agents and Chemotherapy.
[8] E. Goldstein,et al. Pharmacokinetics and Pharmacodynamics of Linezolid in Obese Patients with Cellulitis , 2005, The Annals of pharmacotherapy.